You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 10 No. 5, May 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Posterior Fossa Tumors

Localization With Radioactive Mercury (Hg197 or Hg203) Labeled Chlormerodrin

ALBERT L. RHOTON, JR., MD; ANNA-MARIE CARLSSON, MD; MICHEL M. TER-POGOSSIAN, PhD

Arch Neurol. 1964;10(5):521-526.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Radioisotope scanning techniques are now accepted as a valuable adjunct to classical contrast studies in the localization of intracranial tumors. However, advocates of these methods have not approached supratentorial and subtentorial tumors with equal enthusiasm, the latter being regarded as less amenable to localization by scintiscan techniques. Sweet et al1 utilizing positron emitters characterized their results with posterior fossatumors as "miserable" (59% missed), and McAfee,2 utilizing radioiodinated human serum albumin and scintiscan techniques, obtained "poor" (four of six missed) results with this type of tumor.

Early experience here in localization of posterior fossa tumors utilizing scintillation probe multispot survey over the head after administration of I131 diiodofluorescein was disappointing in that correct localization was suggested in only three of 11 cases.3 More recently we began a program ultilizing further refinements of technique (scanning scintillation detector, effective collimation, and photographic recording) and radiomercury-labeled chlormerodrin. Eighty-four per . . . [Full Text PDF of this Article]


Author Affiliations

ST. LOUIS

From the Division of Neurological Surgery, the Central Clinical Isotope Laboratory and The Mallinckrodt Institute of Radiology, Washington University School of Medicine.

Fellow in Neurological Surgery (Dr. Rhoton); Central Clinical Isotope Laboratory (Dr. Carlsson); Professor of Radiophysics, The Mallinckrodt Institute of Radiology (Dr. Ter-Pogossian).


Footnotes

Submitted for publication Dec 12, 1963; accepted Jan 30, 1964.

This study was aided by a grant from the Allen P. and Josephine B. Green Foundation.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.